Sandra Gracin is a Principal Scientist at AstraZeneca R&D, where they focus on the optimization of formulation processes. They previously served as a Senior Scientist, Associate Principal Scientist, and Sr. Crystallization Scientist at AstraZeneca, specializing in crystallization process development and solid-state expertise. Their earlier experience includes work as a Particle Scientist at GSK, where they supported pharmaceutical crystallization projects. Sandra earned a PhD in Chemical Engineering from Kungliga tekniska högskolan and is currently pursuing an MSc in Chemical Engineering at KTH Royal Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices